Cardiovascular Diseases

Subclinical AF Common in HF Patients

A cohort study revealed that subclinical atrial fibrillation (AF) was common in heart failure (HF) patients with preserved ejection fraction (HFpEF) and mildly reduced ejection fraction (HFmrEF). The study included 367 patients with cardiac monitoring data at baseline and follow-up in a randomized clinical trial of atrial shunt therapy. The median patch monitoring time was 6 and 125 days at baseline and over a 12-month follow-up, respectively. 194 (53%) patients had a history of AF or atrial flutter (AFL), and median baseline AF burden was 0.012%. After multivariable adjustment, baseline AF burden ≥0.012% was significantly associated with HF events (HR: 2.00) regardless of a history of AF or AFL. Adjustment for left atrial reservoir strain attenuated the baseline AF burden-HF event association (HR: 1.71). 141 (38%) patients had patch-detected AF during follow-up without a history of AF or AFL. Atrial shunt therapy did not reduce the total rate of HF events or improve health status, it did not change AF incidence or burden during follow-up either. The findings indicate that subclinical AF is common in patients with HFpEF and HFmrEF and baseline AF burden is associated with HF events. Source: https://www.jacc.org/; https://www.thelancet.com/

hyangiu

Recent Posts

Function-Guided Complete Revascularization Improves Outcomes in STEMI

In patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease, complete coronary…

2 hours ago

2026 Fifth Universal Definition of Myocardial Infarction

The Fifth Universal Definition of Myocardial Infarction (MI) updates the classification of MI by defining…

3 hours ago

Updated US Guideline on Pharmacologic Prevention of Migraine in Adults

The US updated evidence-based recommendations provide clinicians with comprehensive guidance on when to initiate pharmacologic…

8 hours ago

Catheter-Directed Thrombolysis Improves Outcomes in Intermediate-High–Risk Pulmonary Embolism

In patients with intermediate-high–risk acute pulmonary embolism, catheter-directed thrombolysis with alteplase plus anticoagulation significantly reduced…

1 day ago

Atorvastatin Prevents Cardiovascular Events in Older Adults without Prior Cardiovascular Disease

In a large randomized trial, atorvastatin 40 mg daily significantly reduced major cardiovascular events by…

3 days ago

Aficamten Improves Exercise Capacity and Health Status in Nonobstructive HCM

In patients with symptomatic nonobstructive hypertrophic cardiomyopathy (HCM), aficamten significantly improved exercise capacity and patient-reported…

4 days ago

This website uses cookies.